Large-scale testing (Phase 3)Active Not RecruitingNCT06396065What this trial is testingPhase III Study of AK112 for NSCLC PatientsWho this might be right forNon-Squamous Non-small Cell Lung Cancer Summit Therapeutics 420
Testing effectiveness (Phase 2)Ended earlyNCT00549328What this trial is testingMonotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung CancerWho this might be right forLung Cancer, Non-Small Cell GlaxoSmithKline 14
Not applicableLooking for participantsNCT02682667What this trial is testingBiospecimen Procurement for Center for Immuno-Oncology Immunotherapy ProtocolsWho this might be right forMultiple MyelomaLymphoma, Non-HodgkinLeukemia-Lymphoma, Adult T-Cell+2 more National Cancer Institute (NCI) 500
Early research (Phase 1)Looking for participantsNCT06375044What this trial is testingStudy of SIM0500 Alone in Participants With Relapsed or Refractory Multiple MyelomaWho this might be right forRelapsed or Refractory Multiple Myeloma Jiangsu Simcere Pharmaceutical Co., Ltd. 130
Large-scale testing (Phase 3)Ended earlyNCT00083564What this trial is testingStudy Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple MyelomaWho this might be right forMultiple Myeloma Poniard Pharmaceuticals 240
Early research (Phase 1)Ended earlyNCT04855136What this trial is testingSafety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple MyelomaWho this might be right forMultiple Myeloma Celgene 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT05231629What this trial is testingSequential Therapy in Multiple Myeloma Guided by MRD AssessmentsWho this might be right forMultiple Myeloma University of Alabama at Birmingham 300
Early research (Phase 1)Study completedNCT00646139What this trial is testingKX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to TreatmentWho this might be right forLymphomaLymphoproliferative DisorderSmall Intestine Cancer+1 more Roswell Park Cancer Institute 7
Not applicableStudy completedNCT03725475What this trial is testingReveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer PatientsWho this might be right forNon-small-cell Lung Cancer (NSCLC) AstraZeneca 3,111
Testing effectiveness (Phase 2)Study completedNCT00988936What this trial is testingEfficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic DrugWho this might be right forMetastatic Breast CancerMetastatic Colon/Rectum CancerNon-squamous Non-small Cell Lung Cancer Siemens Molecular Imaging 35
Early research (Phase 1)UnknownNCT04357509What this trial is testingThe Tolerance,Pharmacokinetic Characteristics,Safety and Efficacy of ScTIL210 in the Treatment of MelanomaWho this might be right forMelanoma Peking University Cancer Hospital & Institute 32
Testing effectiveness (Phase 2)Study completedNCT03697629What this trial is testingAn Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple MyelomaWho this might be right forMultiple Myeloma in Relapse Canadian Myeloma Research Group 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05715931What this trial is testingPerioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction AdenocarcinomaWho this might be right forAdenocarcinoma of the StomachAdenocarcinoma of Esophagogastric JunctionHER2-positive Gastric Cancer Yu jiren 30
Early research (Phase 1)Study completedNCT06219902What this trial is testingLearn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy WomenWho this might be right forVasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenHot Flashes Bayer 64
Testing effectiveness (Phase 2)Looking for participantsNCT05498428What this trial is testingAmivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-small-Cell Lung Janssen Research & Development, LLC 520
Large-scale testing (Phase 3)Study completedNCT00790400What this trial is testingEfficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)Who this might be right forTuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM) Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)Study completedNCT00003957What this trial is testingCombination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's LymphomaWho this might be right forLymphoma Fox Chase Cancer Center 3
Not applicableStudy completedNCT00525057What this trial is testingDalteparin in Preventing DVT in Participants With CancerWho this might be right forBone SarcomaFemur FractureLymphoma+4 more M.D. Anderson Cancer Center 65
Not applicableNot Yet RecruitingNCT06524219What this trial is testingComparison of Nerve-sparing Techniques in Radical Prostatectomy for Oncological Outcome and Functional Recovery.Who this might be right forProstate Cancer The First Affiliated Hospital with Nanjing Medical University 150
Not applicableLooking for participantsNCT07769892What this trial is testingProspective Observational Cohort Study for Digestive Tract Tumor Screening Using Multi-Target Blood and Fecal BiomarkersWho this might be right forGastrointestinal Cancers Xijing Hospital 5,000